Comparative in vitro activities of seven new beta-lactams, alone and in combination with beta-lactamase inhibitors, against clinical isolates resistant to third generation cephalosporins



Título del documento: Comparative in vitro activities of seven new beta-lactams, alone and in combination with beta-lactamase inhibitors, against clinical isolates resistant to third generation cephalosporins
Revista: The brazilian journal of infectious diseases
Base de datos: PERIÓDICA
Número de sistema: 000291028
ISSN: 1413-8670
Autores: 1


Instituciones: 1Gobierno del Colegio Médico, Hospital del Departamento de Microbiología, Chandigarh, Punjab. India
Año:
Periodo: Feb
Volumen: 10
Número: 1
Paginación: 22-25
País: Brasil
Idioma: Inglés
Tipo de documento: Artículo
Enfoque: Caso clínico
Resumen en inglés We examined the drug susceptibility pattern of Gram-negative bacilli to seven new beta-lactams. A total of 277 non-duplicate gramnegative bacilli strains belonging to the Enterobacteriaceae family, Pseudomonas and Acinetobacter species, isolated from various clinical samples were tested for susceptibility to imipenem, piperacillin/tazobactam, cefoperazone/sulbactam, ticarcillin/clavulanate, cefdinir, cefepime and cefpirome with the disk diffusion technique. The percentage resistance was low for imipenem (7.2%), piperacillin/tazobactam (2.8%), cefoperazone/sulbactam (5.4%). However, a high frequency of resistance was observed to ticarcillin/clavulanate (83.9%), cefdinir (70.6%), cefepime (45.5%) and cefpirome (84.4%). We conclude that imipenem, piperacillin/tazobactam and cefoperazone/sulbactam are effective antibiotics in our environment, whereas ticarcillin/clavulanate, cefdinir, cefepime and cefpirome are relatively uneffective
Disciplinas: Medicina,
Biología,
Química
Palabras clave: Microbiología,
Bacterias,
Bioquímica,
Susceptibilidad,
Medicamentos,
Beta-lactámicos,
Bacilos Gram negativos
Keyword: Medicine,
Biology,
Chemistry,
Microbiology,
Bacteria,
Biochemistry,
Susceptibility,
Drugs,
Beta lactams,
Gram negative bacilli
Texto completo: Texto completo (Ver HTML)